Connect to other sites within the UBM Medica Network
A simple blood test using plasma thermogram could serve as an effective new indicator for detecting cervical cancer, including assessment of the cancer’s stage.
FDA Update: Bevacizumab Is Approved for Cervical Cancer
The FDA has approved bevacizumab (Avastin) for treating persistent, recurrent, or metastatic cervical cancer after studies show gains in overall survival.
Open Hysterectomies More Deadly Than Power Morcellation, Says AAGL
Eradicating morcellators is riskier than using them, says the AAGL in a statement for why these minimally invasive devices should not be abandoned.
Health Insurer to Stop Covering Morcellation
A large insurance company has decided to no longer cover laparoscopic power morcellation. Is this the beginning of the end of power morcellators?
Poll: The Effect of Nursing Quality on Hospital Rankings
The best-ranked hospitals for gynecology have once again been listed by U.S. News & World Report. We noticed a trend—observational only—and want to know what you think.
Hysterectomy Technique May Spread Uterine Cancer
Researchers found that uterine cancers were present in 27 per 10,000 women undergoing morcellation, which fragments the uterus and can spread cancer cells.
Already Had Sex? The HPV Vaccine Still Has Value
The optimal time to get the HPV vaccine is before a first sexual encounter. But getting the vaccine after still offers significant protection against cervical dysplasia.
J&J’s Ethicon Initiates Worldwide Withdrawal of Morcellators
The morcellation controversy heats up as physicians all over the world who use Ethicon power morcellators are being asked to return the medical devices.
Fertility Preservation Options in the Face of Cancer
Your patient just received devastating news: she has cancer. As treatment options and anxieties swirl, more and more women are now faced with another issue: how will the cancer and its treatment impact their fertility?
By clicking Accept, you agree to become a member of the UBM Medica Community.